71655-578 : Ebanga 400 mg/8ml Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 71655-578 |
| Labeler: | Emergent Manufacturing Operations Baltimore, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: | Ebanga |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | BLA761172 |
| Rev. Date: |
NDC Package Codes:
- 71655-578-03: 1 CARTON IN 1 BOX (71655‑578‑03) / 36 VIAL, GLASS IN 1 CARTON (71655‑578‑02) / 8 ML IN 1 VIAL, GLASS (71655‑578‑01)
- 71655-578-04: 4 CARTON IN 1 BOX (71655‑578‑04) / 36 VIAL, GLASS IN 1 CARTON (71655‑578‑02) / 8 ML IN 1 VIAL, GLASS (71655‑578‑01)
- 71655-578-08: 8 CARTON IN 1 BOX (71655‑578‑08) / 36 VIAL, GLASS IN 1 CARTON (71655‑578‑02) / 8 ML IN 1 VIAL, GLASS (71655‑578‑01)
Active Ingredients:
- Ansuvimab
Dosage Strength:
- 400 mg/8mL
Pharmaceutical Classes:
- Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]
- Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]
Related Products:
Based on records with the same trade name.- 80673-777 EbangaEbanga Kit by Ridgeback Biotherapeutics, Lp
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 71655-103Next: 71656-012 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.